Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
21.72 USD | -0.93% | +5.61% | -9.44% |
May. 31 | Exelixis Insider Bought Shares Worth $8,733,955, According to a Recent SEC Filing | MT |
May. 20 | Exelixis Settles Cabometyx Patent Litigation with Cipla | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.44% | 6.39B | |
+16.73% | 121B | |
+13.04% | 107B | |
-5.80% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.00% | 15.31B | |
+1.18% | 14.08B | |
+24.18% | 11.74B |
- Stock Market
- Equities
- EXEL Stock
- News Exelixis, Inc.
- Exelixis Guides For 2024 Revenue of $1.825-$1.925 Billion, vs CIQ Analyst Consensus of $1.91 Billion